HYFT HYFT
Company Profile ↓Company Overview
HYFT (HYFT) is a publicly traded company listed on with a market capitalization of $61.66M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.30.
Recent Developments
- Apr 2026 Revenue of $15.56M (+46.4% YoY); net profit $-13.95M.
- Trailing 12 Months Year-on-year growth — revenue +46.4%.
- 5-Year Trend Long-term compounding — revenue CAGR -9.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -9.03% |
| 1 Year: | 46.41% |
Stock Price Performance
| 1 Year: | -27.87% |
| 6 Months: | -15.92% |
| 3 Months: | +5.60% |
| 1 Month: | -12.58% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)44.50 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -9.0% CAGR over 5 years.
- Trading 58.8% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jan 2025 | Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 6.98M | 3.16M | 4.12M | 4.16M | 4.12M |
| Cost of Revenue | - | 2.52M | 1.63M | 1.46M | 1.69M | 1.62M |
| Gross Profit | - | 4.46M | 1.53M | 2.66M | 2.46M | 2.50M |
| Operating Expenses | - | 5.92M | 5.68M | 5.42M | 6.12M | 6.83M |
| Operating Income | - | -1.46M | -4.15M | -2.76M | -3.66M | -4.33M |
| EBITDA | - | -988.00K | -3.21M | -2.99M | -3.73M | -3.99M |
| Interest Expense | 186.00K | -1.00K | - | 0 | 0 | 0 |
| Pretax Income | - | -1.90M | -4.18M | -3.19M | -3.95M | -4.23M |
| Tax Provision | - | 261.00K | -91.00K | 25.00K | -18.00K | -367.00K |
| Net Income | - | -2.16M | -2.96M | -3.19M | -3.93M | -3.87M |
| Diluted EPS | -0.66 | - | -0.07 | -0.07 | -0.08 | -0.08 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | Apr 2026 |
|---|---|---|---|---|---|
| Revenue | - | 20.66M | 10.28M | 10.63M | 15.56M |
| Cost of Revenue | - | 9.10M | 6.19M | 4.89M | 6.41M |
| Gross Profit | - | 11.56M | 4.09M | 5.73M | 9.15M |
| Operating Expenses | - | 37.17M | 21.30M | 21.32M | 24.05M |
| Operating Income | - | -25.61M | -17.21M | -15.59M | -14.90M |
| EBITDA | - | -21.04M | -26.41M | -32.21M | -13.95M |
| Interest Expense | - | 30.00K | 19.00K | 306.00K | 0 |
| Pretax Income | - | -27.75M | -32.16M | -37.63M | -15.55M |
| Tax Provision | - | -1.19M | -2.86M | -4.48M | -450.00K |
| Net Income | - | -26.56M | -26.11M | -30.23M | -13.95M |
| Diluted EPS | - | -1.07 | -1.02 | -0.90 | -0.31 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | Apr 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 77.81M | 59.99M | 44.44M | 21.38M |
| Current Assets | - | 16.79M | 11.49M | 18.75M | 16.22M |
| Cash & Equivalents | - | 8.28M | 3.46M | 10.66M | 11.35M |
| Inventory | - | 2.06M | 2.14M | 2.10M | 492.00K |
| Receivables | - | 3.25M | 3.79M | 4.12M | 2.53M |
| Total Liabilities | - | 20.01M | 24.31M | 20.82M | 9.63M |
| Current Liabilities | - | 5.92M | 8.12M | 9.01M | 5.79M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 7.27M | 13.68M | 13.40M | 3.53M |
| Total Equity | - | 57.80M | 35.68M | 23.63M | 11.75M |
| Shares Outstanding | - | 25.05M | 26.94M | 46.15M | 46.71M |
Cash Flows (Annual)
Figures in USD.
| Metric | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | Apr 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -19.83M | -3.18M | -6.41M | -12.46M |
| Investing Cash Flow | - | -1.97M | -1.56M | -799.00K | 13.54M |
| Financing Cash Flow | - | -621.00K | 1.02M | 14.89M | 115.00K |
| Capital Expenditure | - | -1.50M | -1.40M | -799.00K | -398.00K |
| Free Cash Flow | - | -21.33M | -4.58M | -7.21M | -12.86M |
| Net Change in Cash | - | -22.42M | -3.73M | 7.68M | 1.20M |
Ratios (Annual)
Figures in %.
| Metric | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | Apr 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 56.0% | 39.8% | 53.9% | 58.8% |
| Operating Margin % | - | -123.9% | -167.4% | -146.7% | -95.8% |
| Net Margin % | - | -128.5% | -254.1% | -284.5% | -89.7% |
| ROE % | - | -45.9% | -73.2% | -128.0% | -118.7% |
| ROCE % | - | -35.6% | -33.2% | -44.0% | -95.6% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for HYFT
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed
American News Group News Commentary - The race to bring artificial intelligence into drug discovery has become one of the most closely watched stories in both biotech and technology. Pharmaceutical companies are pouring money into AI, chipm…
MindWalk Holdings Corp (HYFT) Q4 2026 Earnings Call Highlights: Strong Revenue Growth and ...
MindWalk Holdings Corp (HYFT) reports a 50% increase in Q4 revenue and regains NASDAQ compliance, while focusing on strategic SaaS agreements and operational efficiency.
As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22
Equity Insider News Commentary - Artificial intelligence has moved from the edges of drug discovery to its center. The biggest pharmaceutical companies in the world are now racing to design molecules with machine learning rather than trial …
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2026 on July 22, 2026
AUSTIN, Texas, July 13, 2026--MindWalk Holdings Corp. ("MindWalk" or the "Company") (NASDAQ: HYFT), a Bio-Native AI company, today announced that it will report financial results for the fourth quarter and full fiscal year 2026 and host a c…
MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery
AUSTIN, Texas, July 01, 2026--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced the filing of European patent application No. EP26187897.9, directed to high-dimensional data structures for biologi…
MindWalk Holdings Corp. Q4 2026 Earnings Call Summary
Moby summary of MindWalk Holdings Corp.'s Q4 2026 earnings call
HYFT — Frequently Asked Questions
What is the current share price of HYFT?
As of 2026-08-05 17:25 PDT, HYFT trades at $1.32 on NASDAQ/NYSE. Its 52-week range is $1.02 to $3.20.
What is the market capitalisation of HYFT?
HYFT has a market capitalisation of $61.66M on NASDAQ/NYSE.
What is the P/E ratio of HYFT?
HYFT trades at a trailing price-to-earnings (P/E) ratio of -4.26. Its price-to-book (P/B) ratio is 5.25.
What is the return on equity (ROE) of HYFT?
HYFT has a return on equity (ROE) of -118.72%. Its return on capital employed (ROCE) is -95.62%.
Is HYFT a good stock to buy?
This page provides a data-driven analysis of HYFT, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.